Fundraising Fox
/Companies
Sign in

Fluent Bio

4 known investors

Find your way into Fluent Bio

Sign up to see every warm intro you have to Fluent Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fluent Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries. The software is designed for genomics and life science researchers working with single-cell gene expression data.

BiotechDeveloper Tools

Investors · 4

Cota Capitallisted by Cota CapitalSan Francisco

How we know: Cota Capital's portfolio page · Not right? Tell us

Illumina Ventureslisted by Illumina VenturesFoster City

How we know: Illumina Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Samsara BioCapitallisted by Samsara BioCapitalMenlo Park

How we know: Samsara BioCapital's portfolio page · Not right? Tell us

Related companies · 3

IDbyDNAScalable, high throughput DNA sequencing platforms.
10x Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies working in the same space as Fluent Bio.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.9M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$399.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$299.2K
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$288.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Fluent Bio do?
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries. The software is designed for genomics and life science researchers working with single-cell gene expression data.
Who are Fluent Bio's investors?
Fluent Bio's investors include Civilization Ventures Management, Llc, Cota Capital, Illumina Ventures, Samsara BioCapital.